Published in
Springer, Journal of Cancer Research and Clinical Oncology, 12(146), p. 3359-3369, 2020
DOI: 10.1007/s00432-020-03316-5
Links
Tools
Hyperprogressive disease and its clinical impact in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with immune-checkpoint inhibitors: Korean cancer study group HN 18–12
Journal article published in 2020 by
Jihyun Park,
Sang Hoon Chun 
,
Yun-Gyoo Lee,
Hyun Chang,
Keun-Wook Lee,
Hye Ryun Kim,
Seong Hoon Shin,
Ho Jung An,
Kyoung Eun Lee,
In Gyu Hwang,
Myung-Ju Ahn,
Sung-Bae Kim,
Bhumsuk Keam
,
Yun-Gyoo Lee,
Hyun Chang,
Keun-Wook Lee,
Hye Ryun Kim,
Seong Hoon Shin,
Ho Jung An,
Kyoung Eun Lee,
In Gyu Hwang,
Myung-Ju Ahn,
Sung-Bae Kim,
Bhumsuk Keam
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 